Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The Company is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Post by cool888on Jul 15, 2025 7:53am
59 Views
Post# 36643801

$EMO - An update from @ArgentoCap - thx.

$EMO - An update from @ArgentoCap - thx.Well, that’s a wrap!

The trial just concluded with the final 2 closing statements today coming from counsels for AMC Mining Iberia (GM subsidiary) and Junta De Andalucia.

These and the final three statements yesterday, which included counsel for Grupo Mexico, offered no counter arguments to the incriminating evidence. They attacked Emerita, which given they are not on trial here, seemed like yet another diversion tactic. All theatrics with no substance.

All defendants were present and given the opportunity to close with a few words. Three took advantage of this and could hardly hold back the tears.

The trial could not have gone better for Emerita imo.

Now the wait for the verdict!
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities